Additionally, attaching RGD-TRAIL to the nanoparticles allows the nanoprobe to specifically target the endothelium of tumor neovascularization and the tumor cell surface death receptors DR4 and DR5 [61]. This evidence concerns the gene TNFRSF10B and neoplasm.